physician.accessdmd.com
ACCESS DMD » About ACCESS DMD™ACCESS DMD
http://physician.accessdmd.com/about-access-dmd
About ACCESS DMD ACCESS DMD. Is an expanded access program for children, adolescents, and adults in the U.S. diagnosed with DMD. We invite you to enroll your eligible patients with DMD in the program. The intent of an expanded access program is to provide patients with access to investigational medication for serious diseases or conditions where there is no comparable or satisfactory alternative therapy available. It still carries some of the same regulatory requirements of a clinical trial. Will qualify...
physician.accessdmd.com
ACCESS DMD » Frequently Asked QuestionsACCESS DMD
http://physician.accessdmd.com/faqs
Frequently Asked Questions ACCESS DMD. What is the purpose of an Expanded Access Program (EAP)? The intent of an EAP is to provide patients with access to investigational medication for serious diseases or conditions where there is no comparable or satisfactory alternative therapy available. The FDA has authorized the use of deflazacort* for eligible patients with DMD under the ACCESS DMD. What is the difference between an EAP and a clinical study? Is everyone diagnosed with DMD eligible for this EAP?
marathonpharma.com
Marathon Pharmaceuticals, LLC | Products Archive - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/treatments/products
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Marathon’s branded, prescription medications. This information is intended only for U.S. healthcare professionals. Click on the products below for full prescribing information and other details. Working to ensure our medicine will always be available. Promising new treatments for people with rare diseases. Marathon Pharmaceuticals, LLC. Northbrook, IL 60062.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Rare diseases - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/patients/rare-diseases
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Marathon’s focus is treating rare diseases. Marathon was founded to develop medicines. For rare neurological and movement disorders. We have deep expertise in earning FDA approvals. And getting effective new medicines to. The patients who need them. Marathon Pharmaceuticals is committed to inspiring hope by developing new medicines to treat devastating rare diseases.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Ensuring access - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/treatments/ensuring-access
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Marathon develops branded, prescription medications for patients who need them. We know that medicine has to be available when patients need it. Marathon’s primary objective is working to ensure that patients will have access to an uninterrupted supply of the medically necessary treatments we offer. Marathon’s branded, prescription medications. Northbrook, IL 60062.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Treatments - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/treatments
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Marathon develops branded, prescription medications for patients who need them. Medications for small patient populations. And hard-to-treat rare diseases. Working to ensure our medicine will always be available. Developing new treatments for people with rare diseases. Marathon Pharmaceuticals, LLC. Northbrook, IL 60062. 8211; PHRMA Code. 8211; Safe Harbor.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Team Archive - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/about/team
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Proven leaders in developing rare disease treatments. Desiree Lyon, Executive Director, American Porphyria Foundation. Jeffrey S. Aronin. Executive Vice President, Legal Affairs, Mergers, Acquisitions, and General Counsel. Patrick J. Morris. Executive Vice President, Drug Development. Vice President, Sales and Marketing. Eric J. Messner. Vice President, Public Affairs.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Treatment pipeline - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/advances/treatment-pipeline
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. Marathon was founded to develop new medicines to treat devastating rare diseases. Marathon’s robust pipeline includes medications for rare neurological and movement disorders. We take potential treatments through the development and regulatory processes to benefit patients with unmet medical needs. Investing in new rare disease treatments. Marathon Pharmaceuticals, LLC.
marathonpharma.com
Marathon Pharmaceuticals, LLC | Industry - Marathon Pharmaceuticals, LLC
http://marathonpharma.com/partners/industry
Innovating pharmaceuticals for life. 8211; PHRMA Code. 8211; Safe Harbor. 8211; Compliance Charter. 2016 Marathon Pharmaceuticals, LLC. We can serve patients better by working together. Has a proven track record of success in developing, commercializing and manufacturing important rare-disease treatments. Our corporate structure and financial independence give us the ability to efficiently bring medicines to under-served and overlooked patients. Marathon Pharmaceuticals, LLC. Northbrook, IL 60062.
